Histamine down-regulates IL-27 production in antigen-presenting cells

Journal of Leukocyte Biology

Volumn 92, Issue 1, 2012, Pages 21-29

  Gschwandtner, Maria ^a,b   Bunk, Hannah ^c   Köther, Brigitta ^a   Thurmond, Robin L ^d   Kietzmann, Manfred ^c   Werfel, Thomas ^a   Bäumer, Wolfgang ^c   Gutzmer, Ralf ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Universitatsklinik fur Dermatologie   (Austria)

^c UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^d JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

CXCL10; H2Receptor; H4Receptor; Keratinocyte; Monocyte

Indexed keywords

EBI3 PROTEIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HISTAMINE; HISTAMINE H1 RECEPTOR; HISTAMINE H2 RECEPTOR; HISTAMINE H3 RECEPTOR; HISTAMINE H4 RECEPTOR; HISTAMINE RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 27; INTERLEUKIN 6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN; PROTEIN P28; STAT1 PROTEIN; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SUPERNATANT;

ANIMALS; ANTIGEN-PRESENTING CELLS; BLOTTING, WESTERN; CELLS, CULTURED; DENDRITIC CELLS; DOWN-REGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; HISTAMINE; HISTAMINE AGONISTS; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-6; INTERLEUKINS; KERATINOCYTES; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MONOCYTES; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, HISTAMINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

MUS;

EID: 84863480986     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0111017     Document Type: Article

References (32)

1. O'Mahony, L., Akdis, M., Akdis, C. A. (2011) Regulation of the immune response and inflammation by histamine and histaminereceptors. J. Allergy Clin. Immunol. 128, 1153-1162.
2. Tiligada, E., Zampeli, E., Sander, K, Stark, H. (2009) Histamine H3 and H4 receptors as novel drug targets. Expert Opin. Investig. Drugs 18, 1519-1531.
3. Hofstra, C. L., Desai, P. J., Thurmond, R. L., Fung-Leung, W. P. (2003) Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells. J Pharmacol. Exp. Ther. 305, 1212-1221.
4. Gutzmer, R, Diestel, C, Mommert, S., Kother, B., Stark, H., Wittmann, M., Werfel, T. (2005) Histamine H4 receptor stimulation suppresses IL-12p70 production and mediates chemotaxis in human monocyte-derived dendritic cells.J. Immunol. 174, 5224-5232.
5. Ling, P., Ngo, K., Nguyen, S., Thurmond, R L., Edwards, J. P., Karlsson, L., Fung-Leung, W. P. (2004) Histamine H4 receptor mediates eosinophil chemotaxis with cell shape change and adhesion molecule upregu-lation. Br. J. Pharmacol. 142, 161-171.
6. Gantner, F., Sakai, K., Tusche, M. W., Cruikshank, W. W., Center, D. M., Bacon, K. B. (2002) Histamine h(4) and h(2) receptors control hista-mine-induced interleukin-16 release from human CD8(+) T cells. J. Pharmacol. Exp. Ther. 303, 300-307.
7. Gutzmer, R, Mommert, S., Gschwandtner, M., Zwingmann, K, Stark, H., Werfel, T. (2009) The histamine H4 receptor is functionally expressed on T(H)2 cells. J. Allergy Clin. Immunol. 123, 619-625.
8. Dijkstra, D., Stark, H., Chazot, P.L., Shenton, F.C., Leurs, R, Werfel, T., Gutzmer, R (2008) Human inflammatory dendritic epidermal cells express a functional histamine H4 receptor.J. Invest. Dermatol. 128, 1696-1703.
9. Gschwandtner, M., Rossbach, K, Dijkstra, D., Baumer, W., Kietzmann, M., Stark, H., Werfel, T., Gutzmer, R (2010) Murine and human Lang-erhans cells express a functional histamine H receptor: modulation of cell migration and function. Allergy 65, 840-849.
10. Devergne, O., Hummel, M., Koeppen, H., Le Beau, M. M., Nathanson, E. C, Kieff, E., Birkenbach, M. (1996) A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes. J. Virol. 70, 1143-1153.
11. Devergne, O., Birkenbach, M., Kieff, E. (1997) Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel het-erodimeric hematopoietin. Proc. Natl. Acad. Sci. USA 94, 12041-12046.
12. Pflanz, S., Timans, J. C, Cheung, J., Rosales, R, Kanzler, H., Gilbert, J., Hibbert, L., Churakova, T., Travis, M., Vaisberg, E., Blumenschein, W. M., Mattson, J. D., Wagner, J. L., To, W., Zurawski, S., McClanahan, T. K, Gorman, D. M., Bazan, J. F., de Waal Malefyt, R, Rennick, D., Kastelein, R A. (2002) IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity 16, 779-790.
13. Wirtz, S., Becker, C, Fantini, M. C, Nieuwenhuis, E. E., Tubbe, I., Galle, P. R, Schild, H. J., Birkenbach, M., Blumberg, R S., Neurath, M. F. (2005) EBV-induced gene 3 transcription is induced by TLR signaling in primary dendritic cells via NF-k B activation. J. Immunol. 174, 2814-2824.
14. Pflanz, S., Hibbert, L., Mattson, J., Rosales, R, Vaisberg, E., Bazan, J. F., Phillips, J. H., McClanahan, T. K., de Waal, M. R, Kastelein, R A. (2004) WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. J. Immunol. 172, 2225-2231.
15. Chen, Q., Ghilardi, N., Wang, H., Baker, T, Xie, M. H., Gurney, A, Gre-wal, I. S., de Sauvage, F. J. (2000) Development of Th1-type immune responses requires the type I cytokine receptor TCCR Nature 407, 916-920.
16. Yoshida, H., Hamano, S., Senaldi, G., Covey, T., Faggioni, R, Mu, S., Xia, M., Wakeham, A. C, Nishina, H., Potter, J., Saris, C. J., Mak, T. W. (2001) WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection. Immunity 15, 569-578.
17. Wittmann, M., Zeitvogel, J., Wang, D., Werfel, T. (2009) IL-27 is expressed in chronic human eczematous skin lesions and stimulates human keratinocytes. J. Allergy Clin. Immunol. 124, 81-89.
18. Shibata, S., Tada, Y., Kanda, N., Nashiro, K, Kamata, M., Karakawa, M., Miyagaki, T., Kai, H., Saeki, H., Shirakata, Y, Watanabe, S., Tamaki, K, Sato, S. (2010) Possible roles of IL-27 in the pathogenesis of psoriasis. J. Invest. Dermatol. 130, 1034-1039.
19. Krogstad, A. L., Lonnroth, P., Larson, G., Wallin, B. G. (1997) Increased interstitial histamine concentration in the psoriatic plaque. J. Invest. Dermatol. 109, 632-635.
20. Ruzicka, T., Simmet, T., Peskar, B. A, Ring, J. (1986) Skin levels of arachidonic acid-derived inflammatory mediators and histamine in atopic dermatitis and psoriasis. J. Invest. Dermatol. 86, 105-108.
21. Morath, S., Geyer, A, Hartung, T. (2001) Structure-function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus. J. Exp. Med. 193, 393-397.
22. Baumer, W., Wendorff, S., Gutzmer, R, Werfel, T., Dijkstra, D., Chazot, P., Stark, H., Kietzmann, M. (2008) Histamine H4 receptors modulate dendritic cell migration through skin-immunomodulatory role of histamine. Allergy 63, 1387-1394.
23. Witmann, M., Zwirner, J., Larsson, V A, Kirchhoff, K, Begemann, G., Kapp, A, Götze, O., Werfel, T. (1999) C5a suppresses the production of IL-12 by IFN-γ-primed and lipopolysachharide-challenged human monocytes. J. Immunol. 162, 6763-6769.
24. Horr, B., Borck, H, Thurmond, R, Grosch, S., Diel, F. (2006) STAT1 phosphorylation and cleavage is regulated by the histamine (H4) receptor in human atopic and non-atopic lymphocytes. Int. Immunopharmacol. 6, 1577-1585.
25. Morse, K L., Behan, J., Laz, T M., West Jr., R E., Greenfeder, S. A, An-thes, J. C, Umland, S., Wan, Y, Hipkin, R W., Gonsiorek, W., Shin, N., Gustafson, E. L., Qiao, X., Wang, S., Hedrick, J. A, Greene, J., Bayne, M., Monsma Jr., F. J. (2001) HCloning and characterization of a novel human histamine receptor.J. Pharmacol. Exp. Ther. 296, 1058-1066.
26. Molle, C, Goldman, M., Goriely, S. (2010) Critical role of the IFN-stimulated gene factor 3 complex in TLR-mediated IL-27p28 gene expression revealing a two-step activation process. J. Immunol. 184, 1784-1792.
27. May, M. J., Ghosh, S. (1998) Signal transduction through NF-k B. Immunol. Today 19, 80-88.
28. Foey, A. D., Parry, S. L., Williams, L. M., Feldmann, M., Foxwell, B. M., Brennan, F. M. (1998) Regulation of monocyte IL-10 synthesis by endogenous IL-1 and TNF-α: role of the p38 and p42/44 mitogen-activated protein kinases. J. Immunol. 160, 920-928.
29. Kimura, A, Naka, T., Muta, T., Takeuchi, O., Akira, S., Kawase, I., Kishimoto, T. (2005) Suppressor of cytokine signaling-1 selectively inhibits LPS-induced IL-6 production by regulating JAK-STAT. Proc. Natl. Acad. Sci. USA 102, 17089-17094.
30. Van der Bruggen, T., Nijenhuis, S., van, R E., Verhoef, J., van Asbeck, B. S. (1999) Lipopolysaccharide-induced tumor necrosis factor α production by human monocytes involves the raf-1/MEK1-MEK2/ERK1-ERK2 pathway. Infect. Immun. 67, 3824-3829.
31. Dunford, P. J., O'Donnell, N., Riley, J. P., Williams, K. N., Karlsson, L., Thurmond, R L. (2006) The histamine H4 receptor mediates allergic airway inflammation by regulating the activation of CD4+ T cells. J. Immunol. 176, 7062-7070.
32. Lim, H. D., Van Rijn, R M., Ling, P., Bakker, R A, Thurmond, R L., Leurs, R (2005) Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: identification of 4-methyl-histamine as the first potent and selective H4 receptor agonist. J. Pharmacol. Exp. Ther. 314, 1310-1321.